#United States #Analog Devices #Wilmington #Board of Directors #Andrea Wainer

Analog Devices Strengthens Leadership with New Board Member

Analog Devices, Inc. (NASDAQ: ADI) recently announced an important addition to its board of directors: Andrea F. Wainer, a highly experienced leader in the healthcare sector. Her appointment marks a significant move for the company as it aims to leverage her extensive expertise to navigate future opportunities in the semiconductor industry.

Vincent Roche, CEO and Chair of Analog Devices, expressed enthusiasm about Wainer joining the board, highlighting her vast experience as a valuable asset for the company. Roche emphasized, "We are thrilled to welcome Andrea to the ADI Board; her substantial background in healthcare will provide ADI with critical insights as we explore the potential ahead."

A Proven Track Record in Healthcare

Wainer brings with her a wealth of knowledge and experience, having held various high-ranking positions in leading pharmaceutical companies. She is currently the Executive Vice President of Rapid and Molecular Diagnostics at Abbott Laboratories, where she has been instrumental in managing three distinct business lines—focused on molecular diagnostics, rapid point-of-care diagnostics, and handheld diagnostic devices.

Prior to her role at Abbott, Wainer held several leadership positions at prominent firms such as Pfizer and Astellas Pharma. Her ability to drive innovative solutions and strategic growth within these organizations is well-recognized in the industry. Wainer's leadership has been reflective of her commitment to deploying advanced technology to improve patient care and streamline diagnostic processes.

Additionally, Wainer is actively involved in the community; she is a member of the Board of Trustees at the Goodman Theatre, showcasing her passion for the arts and commitment to social responsibility.

Academic Credentials

Andrea F. Wainer holds a Bachelor's degree in Accounting from the John M. Olin School of Business at Washington University and an MBA from the Kellogg School of Management at Northwestern University. Her academic background, combined with her vast professional experience, positions her as a thoughtful and strategic leader who understands the complexities of both the healthcare and technology landscapes.

About Analog Devices

Analog Devices, Inc. is recognized as a global leader in semiconductors, focusing on bridging the gap between the physical and digital realms. The company's innovative solutions drive advancements in various sectors, including digital healthcare, transportation, and climate change initiatives. With a revenue exceeding $9 billion for the fiscal year 2024 and a diverse workforce of approximately 24,000 employees worldwide, Analog Devices is committed to inspiring continuous innovation.

The appointment of Andrea F. Wainer not only strengthens Analog Devices' board but also underscores the company's commitment to integrating diverse perspectives into its leadership structure. As the semiconductor industry continues to evolve, Wainer's rich experience in the healthcare domain will undoubtedly provide valuable insights as ADI seeks to tackle the challenges and opportunities that lie ahead.

For more information about Analog Devices and its initiatives, visit Analog Devices Website.